NIH's limited competition supports institutions in historically underfunded states to build biomedical research capacity through early-career recruitment, mentoring, facilities, and administrative support.
Funder: National Institutes of Health
Due Dates: January 25, 2027 (Application) | May 25, 2027 (Application) | September 25, 2027 (Application) | January 25, 2028 (Application) | May 25, 2028 (Application) | September 25, 2028 (Application) | January 25, 2029 (Application) | May 25, 2029 (Application) | May 26, 2029 (Closing)
Funding Amounts: Up to $400,000 direct costs in year 1 and $1.8 million annually in years 2–5; maximum five years
Summary: Builds biomedical research capacity at less-resourced institutions in IDeA jurisdictions through faculty recruitment, mentoring, facilities, and research administration.
Key Information: Institutions must have no active COBRE grants at submission, including grants in no-cost extension.
The Centers of Biomedical Research Excellence Development Phase (COBRE-D) is a limited-competition P30 program administered by the National Institute of General Medical Sciences (NIGMS) within NIH’s Institutional Development Award (IDeA) program. It supports institutions in jurisdictions that historically received low levels of NIH funding, targeting broad biomedical scientific areas of strategic institutional importance where infrastructure and investigator expertise are lacking.
Awards support recruitment and mentoring of three to six early- to mid-career investigators, supplemental start-up packages, research facilities, and stronger research administration. An initial ramp-up period of up to 12 months establishes the organizational framework. COBRE-D is an on-ramp to the COBRE Expansion and Sustainability phases, rather than support for an already-developed research area. Clinical trials are not allowed, although human-subjects activities that are not clinical trials may be proposed.